Monoclonal antibodies represent important weapons in our arsenal to against the COVID-19 pandemic. However, this potential is severely limited by the time-consuming process of developing effective antibodies and the relative high cost of manufacturing. Herein, we present a rapid and cost-effective lipid nanoparticle (LNP) encapsulated-mRNA platform for in vivo delivery of SARS-CoV-2 neutralization antibodies. Two mRNAs encoding the light and heavy chains of a potent SARS-CoV-2 neutralizing antibody HB27, which is currently being evaluated in clinical trials, were encapsulated into clinical grade LNP formulations (named as mRNA-HB27-LNP). In vivo characterization demonstrated that intravenous administration of mRNA-HB27-LNP in mice resulted in a longer circulating half-life compared with the original HB27 antibody in protein format. More importantly, a single prophylactic administration of mRNA-HB27-LNP provided protection against SARS-CoV-2 challenge in mice at 1, 7 and even 63 days post administration. In a close contact transmission model, prophylactic administration of mRNA-HB27-LNP prevented SARS-CoV-2 infection between hamsters in a dose-dependent manner. Overall, our results demonstrate a superior long-term protection against SARS-CoV-2 conferred by a single administration of this unique mRNA antibody, highlighting the potential of this universal platform for antibody-based disease prevention and therapy against COVID-19 as well as a variety of other infectious diseases.
【저자키워드】 immunology, Biological techniques, 【초록키워드】 COVID-19, antibodies, SARS-CoV-2, therapy, Diseases, antibody, SARS-COV-2 infection, COVID-19 pandemic, clinical trials, Prophylactic, LNP, Protein, mice, mRNA, Transmission model, hamster, in vivo, disease, platform, SARS-CoV-2 neutralization, SARS-CoV-2 neutralizing antibody, administration, close contact, intravenous, heavy chain, dose-dependent manner, circulating, effective, evaluated, provided, unique, variety, demonstrated, prevented, highlighting, time-consuming, 【제목키워드】 SARS-CoV-2, antibody, mice, mRNA, hamster, Lipid, provide,